Citric Acid

Citric Acid

SCHEMBL447074

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Ca+2].[Cl-].[Cl-].[Na+].[Na+].[Na+]

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.90
CASP1 P29466 1/20 0.35
FFAR3 O14843 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL29374581 0.97 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL212319 0.97 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL9299265 0.97 CA4 (0.84) CA4CASP1ALDH1A1
Citric Acid SCHEMBL1065771 0.97 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL8066143 0.97 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL15173183 0.97 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL4818290 0.95 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL21626215 0.95 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL29051415 0.95 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL2787196 0.95 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105640925-B Dried powder formula and method for treating pulmonary disease 普马特里克斯营业公司 2019-08-16 CN disclosed
CN-108434126-A Treat the dry powder formulation and method of tuberculosis 普马特里克斯营业公司 2018-08-24 CN disclosed
CN-103200938-B Dry powder formulations and methods for treating pulmonary diseases 普马特里克斯营业公司 2018-07-31 CN disclosed
US-20180153996-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX OPERATING CO INC (US) 2018-06-07 US disclosed
CN-102497853-B Dry powder formulations and methods for treating pulmonary diseases 普马特里克斯营业公司 2018-03-23 CN disclosed
US-9238005-B2 Dry powder formulations and methods for treating pulmonary diseases PULMATRIX OPERATING COMPANY, INC. (US) 2016-01-19 US disclosed
US-9233158-B2 Dry powder formulations and methods for treating pulmonary diseases PULMATRIX, INC. (US) 2016-01-12 US disclosed
US-20150335573-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX OPERATING COMPANY, INC. 2015-11-26 US disclosed
US-20150250875-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX, INC. 2015-09-10 US disclosed
US-9119778-B2 Dry powder formulations and methods for treating pulmonary diseases PULMATRIX OPERATING COMPANY, INC. (US) 2015-09-01 US disclosed
US-20150196486-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX OPERATING COMPANY, INC. 2015-07-16 US disclosed
US-9061352-B2 Dry powder formulations and methods for treating pulmonary diseases PULMATRIX, INC. (US) 2015-06-23 US disclosed
US-20130213398-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX OPERATING COMPANY, INC. 2013-08-22 US disclosed
CN-103200938-A Dry powder formulations and methods for treating pulmonary diseases PULMATRIX INC 2013-07-10 CN disclosed
CN-102497853-A Dry powder formulations and methods for treating pulmonary diseases PULMATRIX INC 2012-06-13 CN disclosed
US-20120064126-A1 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES PULMATRIX, INC. (US) 2012-03-15 US disclosed